Effects and safety of periconceptional folate supplementation for preventing birth defects

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  De Regil, Luz Maria ^a   Fernández Gaxiola, Ana C ^b   Dowswell, Therese ^c   Peña Rosas, Juan Pablo ^d  

^a UNIVERSIDAD IBEROAMERICANA   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; FOLIC ACID; PLACEBO; TRACE ELEMENT;

CLEFT LIP; CLEFT PALATE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DATA EXTRACTION; DRUG SAFETY; FOLIC ACID DEFICIENCY; HUMAN; INTERVENTION STUDY; NEURAL TUBE DEFECT; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 70049108523     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007950     Document Type: Review

References (62)

1. Berry RJ, Kihlberg R, Devine O. Impact of misclassification of in vitro fertilization in studies of folic acid and twinning: modeling using population based Swedish vital records. BMJ 2005;330:815-818 (Pubitemid 40529799)
2. Berry RJ. Report for FFI technical workshop on folic acid fortification of flour. CDC, 2009.
3. Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, De Vigan C, et al.Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Research Part A. Clinical and Molecular Teratology 2006;76:693-705. (Pubitemid 44655984)
4. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. American Journal of Medical Genetics Part C. Seminars in Medical Genetics 2004;125C(1):12-21.
5. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et al.International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. BMJ 2005;330:571-573 (Pubitemid 40380351)
6. Busby A, Abramsky L, Dolk H, Armstrong B, Addor MC, Anneren G, et al.Preventing neural tube defects in Europe: a missed opportunity. Reproductive Toxicology 2006;20:393-402. (Pubitemid 40943559)
7. Centers for Disease Control and Prevention. National Report on Biochemical Indicators of Diet and Nutrition in the US Population 1999-2002. Water soluble vitamins and related biochemical compounds. Atlanta, GA: Department of Health and Human Services, 2008.
8. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, et al.A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Molecular Genetics and Metabolism 2000;70(4):310-315 (Pubitemid 30736432)
9. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al.Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297(21):2351-2359 (Pubitemid 46883748)
10. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992;327(26):1832-1835 (Pubitemid 23003073)
11. Czeizel AE, Metneki J, Dudas I. The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes. Acta Geneticae Medicae et Gemellologiae 1994;43(3-4):175-184
12. Czeizel AE. Periconceptional folic acid andmultivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Research Part A. Clinical and Molecular Teratology 2009;85(4):260-268
13. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
14. English M, Snow RW. Iron and folic acid supplementation and malaria risk. Lancet 2006;367(9505):90-91 (Pubitemid 43077110)
15. Ericson A, Kallen B, Aberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Research 2001;4(2):63-66 (Pubitemid 32521718)
16. Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. Journal of Obstetrics and Gynaecology Canada: JOGC 2006;28:680-689
17. Haider BA, Bhutta ZA.Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD004905.pub2]
18. Haider BA, Humayun Q, Bhutta ZA, Jabeen A. Folate supplementation in pregnancy. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006896]
19. Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. British Journal of Nutrition 2008 in press.
20. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook.org.
21. Houghton LA, Sherwood KL, Pawlosky R, Ito S, O'Connor DL. [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. American Journal of Clinical Nutrition 2006;83(4):842-850 (Pubitemid 44713149)
22. Bale JR, Stoll BJ, Lucas AO, editors. Reducing birth defects: meet- ing the challenge in the developing world. Washington: National Academies Press, 2003.
23. Iyengar L, Rajalakshmi K. Effect of folic acid supplement on birth weights of infants. American Journal of Obstetrics and Gynecology 1975;122(3):332-336
24. Kucik J, Correa A. Trends in twinning rates in metropolitan Atlanta before and after folic acid fortification. Journal of Reproductive Medicine 2004;49(9):707-712 (Pubitemid 39244918)
25. Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. American Journal of Clinical Nutrition 2004;79(3):473-478 (Pubitemid 41115593)
26. Li Z, Gindler J, Wang H, Berry RJ, Li S, Correa A, et al.Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet 2003;361(9355):380-384 (Pubitemid 36164970)
27. Life Sciences Research Office, Center for Food Safety and Applied Nutrition. Assessment of folate methodology used in the Third National Health and Nutrition Survey (NHANES 1988-1994). Washington DC: U.S. Food and Drug Administration, Department of Health and Human Services, 1994.
28. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001056]
29. Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, Vrazioti V, et al.Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Archives of Gynecology & Obstetrics 2007;275(2):121-124 (Pubitemid 46360641)
30. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, et al.A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiology, Biomarkers & Prevention 2007;16(7):1325-1329 (Pubitemid 47076861)
31. McNulty H, Pentieva K. Folate bioavailability. Proceedings of the Nutrition Society 2004;63(4):529-536
32. Modell B, Kuliev AM. Impact of public health on human genetics. Clinical Genetics 1989;36(5):286-298 (Pubitemid 20006605)
33. Anonymous. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338(8760):131-137
34. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet 1997;349(9062):1347-1352
35. Nduati E, Diriye A, Ommeh S, Mwai L, Kiara S, Masseno V, et al.Effect of folate derivatives on the activity of antifolate drugs used againstmalaria and cancer. Parasitology Research 2008;102(6):1227-1234
36. Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts JM. Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension 2004;43(6):1279-1282
37. Pena-Rosas JP, Viteri FE. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004736.pub2]
38. Refsum H, Smith AD. Are we ready for mandatory fortification with vitamin B-12?. American Journal of Clinical Nutrition 2008;88(2):253-254
39. Relton CL, Pearce MS, Parker L. The influence of erythrocyte folate and serum vitamin B12 status on birth weight. British Journal of Nutrition 2005;93(5):593-599 (Pubitemid 43906342)
40. Reveiz L, Gyte GM, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD003094.pub2]
41. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
42. Rolschau J, Kristoffersen K, Ulrich M, Grinsted P, Schaumburg E, Foged N. The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. European Journal of Obstetrics & Gynecology and Reproductive Biology 1999;87 (2):105-10; discussion 103-104 (Pubitemid 29476524)
43. Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food & Nutrition Bulletin 2008;29(2 Suppl):S67-S73.
44. Shaw GM, Carmichael SL, Nelson V, Selvin S, Schaffer DM. Food fortification with folic acid and twinning among California infants. American Journal of Medical Genetics 2003;119A:137-140 (Pubitemid 37063881)
45. Shibuya K, Murray C.Congenital anomalies. In: Murray C, Lopez A editor(s). Health dimensions of sex and reproduction. Boston: Harvard School of Public Health, 1998:463-473
46. Signore C, Mills JL, Cox C, Trumble AC. Effects of folic acid fortification on twin gestation rates. Obstetrics & Gynecology 2005;105:757-762 (Pubitemid 40432193)
47. Tamura T, Picciano MF. Folate and human reproduction. American Journal of Clinical Nutrition 2006;83(5):993-1016.
48. Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al.A second commonmutation in themethylenetetrahy-drofolate reductase gene: an additional risk factor for neural-tube defects?. American Journal of Human Genetics 1998;62(5):1044-1051 (Pubitemid 28199004)
49. Van Eijk AM, Ouma PO, Williamson J, Ter Kuile FO, Parise M, Otieno K, et al.Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western Kenya who have uncomplicated malaria. Journal of Infectious Diseases 2008;198(10):1550-1553
50. Venn BJ, Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. Journal of Nutrition 2002;132(11):3353-3355 (Pubitemid 35304243)
51. Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. American Journal of Clinical Nutrition 2003;77(3):658-662 (Pubitemid 36258576)
52. Vollset SE, Gjessing HK, Tandberg A, Ronning T, Irgens LM, Baste V, et al.Folate supplementation and twin pregnancies. Epidemiology 2005;16(2):201-205
53. Alwan AA, Modell B, editors. Community control of genetic and congenital disorders. Alexandria: WHO, 1997.
54. World Health Organization. Human genetics: services for the prevention and management of genetic disorders and birth defects in developing countries. Report of a joint WHO/WOAPBD Meeting. Geneva: WHO, 1999.
55. World Health Organization. Primary health care approaches for the prevention and control of congenital genetic disorders. Report of a WHO meeting. Geneva: WHO, 2000.
56. Ahman E, Zupan J. Neonatal and perinatal mortality. Country, regional and global estimates 2004. Geneva: Department of Making Pregnancy Safer, WHO, 2004.
57. World Health Organization. Prevention of neural tube defects. Standards for maternal and neonatal care. www.who.int/reproductivehealth/publications/ standards/neural-tube-defects.pdf (accessed 22 January 2009).
58. World Health Organization. Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food and Nutrition Bulletin 2008;29(2 Suppl):S238-S244.
59. World Health Organization. Weekly iron-folic acid supplementation (WIFS) in women of reproductive age: its role in promoting optimal maternal and child health. Position statement. www.who.int/nutrition (accessed 23 January 2009).
60. Wilcken DE. MTHFR 677C - >T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 1997;350(9078):603-604
61. Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, et al.Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007;334(7591):464. (Pubitemid 46586604)
62. Yajnik CS, Deshmukh US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Reviews in Endocrine & Metabolic Disorders 2008;9(3):203-211